![Monika Tornsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Monika Tornsen
Chief Operating Officer at
HANSA BIOPHARMA AB
Profile
Monika Maria Tornsen is currently Chief Operating Officer & President-US Region at Hansa Biopharma AB since 2025.
Former roles include Independent Director at Immunic, Inc., President-North America at Calliditas Therapeutics AB from 2024 to 2025, Senior Vice President & General Manager-US at Sarepta Therapeutics, Inc. from 2019 to 2021, Vice President-Global Therapeutic at Genzyme Corp.
from 2017 to 2019, and Chief Commercial Officer at Passage Bio, Inc. from 2021 to 2022.
Education includes graduate studies at the University of Lund.
Monika Tornsen active positions
| Companies | Position | Start |
|---|---|---|
| HANSA BIOPHARMA AB | Chief Operating Officer | 2025-05-18 |
Former positions of Monika Tornsen
| Companies | Position | End |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 2024-12-31 |
| PASSAGE BIO, INC. | Corporate Officer/Principal | 2022-11-30 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-12-31 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 2018-12-31 |
| IMMUNIC, INC. | Director/Board Member | - |
Training of Monika Tornsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Monika Tornsen
